How brain-derived exosomes relate to Alzheimer's disease and cognitive decline after traumatic brain injury.
Impact of TBI and Cognitive Decline on Alzheimer's Disease Brain-Derived Exosome Cargo
This study is looking at tiny particles in the blood that come from the brain to see how they might help us understand Alzheimer's disease, especially in people who have had a head injury, and it hopes to find clues that could help track how the disease progresses in older adults.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10662883 on NIH RePORTER |
What this research studies
This research investigates the role of brain-derived exosomes in Alzheimer's disease, particularly focusing on how traumatic brain injury (TBI) may influence cognitive decline. By analyzing exosomes from plasma, which carry specific proteins related to brain health, the study aims to identify biomarkers that could indicate the progression of Alzheimer's disease. The research utilizes existing plasma samples to explore the connection between exosome protein content and cognitive changes in older adults, providing insights into potential diagnostic tools for Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who have experienced traumatic brain injury and are showing signs of cognitive decline.
Not a fit: Patients who do not have a history of traumatic brain injury or those who are not experiencing cognitive decline may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic methods for Alzheimer's disease, allowing for earlier detection and better management of the condition.
How similar studies have performed: Previous research has shown promise in using exosome biomarkers for neurodegenerative diseases, indicating that this approach may yield valuable insights.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Rissman, Robert — University of Southern California
- Study coordinator: Rissman, Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.